Article
Zika Virus: A New Therapeutic Candidate for Glioblastoma Treatment
12 Oct 2021
Abstract excerpt
Glioblastoma (GBM) is the most aggressive among the neurological tumors. At present, no chemotherapy or radiotherapy regimen is associated with a positive long-term outcome. In the majority of cases, the tumor recurs within 32–36 weeks of initial treatment. The recent discovery that Zika virus (ZIKV) has an oncolytic action against GBM has brought hope for the development of new therapeutic approaches. ZIKV is an...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
